Mechanisms whereby calcium channel antagonists may protect patients with coronary artery disease.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/18.SUPPL_A.92PMID 9049544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Reduction in CK- and CKMB-measured infarct size by verapamil].

  2008cited by this paper
• Doppler flow and echocardiography in functional cardiac insufficiency: assessment of nisoldipine therapy. Results of the DEFIANT-II Study. The DEFIANT-II Research Group.

  1997cited by this paper
• Verapamil following uncomplicated myocardial infarction: promising, but not proven.

  1996cited by this paper
• Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm.

  1996cited by this paper
• Corrections to the nifedipine meta-analysis.

  1996cited by this paper
• Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS)

  1996cited by this paper
• Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension.

  1996cited by this paper
• A controlled trial of verapamil in patients after acute myocardial infarction: results of the calcium antagonist reinfarction Italian study (CRIS)

  1996cited by this paper
• Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.

  1996cited by this paper
• Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.

  1996cited by this paper
• Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris.

  1995cited by this paper
• Diagnosing and managing unstable angina.

  1995cited by this paper
• Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.

  1995cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

  1995cited by this paper
• Nifedipine and mortality. Grave defects in the dossier.

  1995cited by this paper
• Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group.

  1995cited by this paper
• Investigation of therapeutic mechanisms of atenolol and diltiazem in patients with variable-threshold angina.

  1994cited by this paper
• Effect of nifedipine on coronary capillary geometry in normotensive and hypertensive rats.

  1994cited by this paper
• The Calcium Modulator Nifedipine Exerts Its Antiaggregatory Property via a Nitric Oxide Mediated Process

  1994cited by this paper
• Diagnosing and managing unstable angina. Agency for Health Care Policy and Research.

  1994cited by this paper
• Unstable angina : diagnosis and management

  1994cited by this paper
• Verapamil prevents sudden death in patients with increased heart size after an acute myocardial infarction

  1993cited by this paper
• Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.

  1993cited by this paper
• Calcium-channel antagonists.

  1993cited by this paper
• A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients.

  1993cited by this paper
• Circadian Variations in Ischemic Threshold and Their Relation to the Occurrence of Ischemic Episodes

  1993cited by this paper
• The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

  1993cited by this paper
• Failure of Calcium Channel Blockers to Improve Ventricular Relaxation in Humans

  1993cited by this paper
• Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.

  1993cited by this paper
• Reduction of endothelin levels by the dihydropyridine calcium antagonist nisoldipine and a 'natural factor' in cultured human endothelial cells

  1993cited by this paper
• Selectivity Scale of Calcium Antagonists in the Human Cardiovascular System Based on In Vitro Studies

  1992cited by this paper
• Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.

  1992cited by this paper
• The Calcium Antagonist Nisoldipine Improves the Functional Recovery of Reperfused Myocardium Only When Given Before Ischemia

  1992cited by this paper
• Hemodynamic effects of nisoldipine, a highly specific calcium antagonist, in patients with acute myocardial infarction

  1992cited by this paper
• Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion.

  1992cited by this paper
• Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post myocardial infarction: results of the DEFIANT study. Doppler Flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy.

  1992cited by this paper
• Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy.

  1992cited by this paper
• Diastolic Ventricular Dysfunction in Noncomplicated Acute Myocardial Infarction: The Influence of Gallopamil

  1992cited by this paper
• Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension.

  1992cited by this paper
• Relation of regression of left ventricular hypertrophy to changes in ambulatory blood pressure after long-term therapy with perindopril versus nifedipine.

  1992cited by this paper
• Attenuation of the circadian patterns of myocardial ischemia with nifedipine GITS in patients with chronic stable angina. N-CAP Study Group.

  1992cited by this paper
• Randomized,multicenter,double-blind,placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure

  1991cited by this paper
• The Antiarrhythmic and Antifibrillatory Effects of Calcium Antagonists

  1991cited by this paper
• Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension.

  1991cited by this paper
• Update of effects of calcium antagonists in myocardial infarction or angina in light of the second Danish Verapamil Infarction Trial (DAVIT-II) and other recent studies.

  1991cited by this paper
• An 8-week double-blind study of amlodipine and diltiazem in patients with stable exertional angina pectoris.

  1991cited by this paper
• Transient myocardial ischemia during daily life in rest and exertional angina pectoris and comparison of effectiveness of metoprolol versus nifedipine.

  1991cited by this paper
• Diltiazem inhibition of sodium-induced calcium release. Effects on energy metabolism of heart mitochondria.

  1991cited by this paper
• Open comparative study to assess the efficacy and safety of two calcium antagonists: amlodipine and diltiazem in the treatment of symptomatic myocardial ischemia.

  1991cited by this paper
• Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement.

  1991cited by this paper
• Double‐Blind, Dose‐Response, Placebo‐Controlled Multicenter Study of Nisoldipine: A New Second‐Generation Calcium Channel Blocker in Angina Pectoris

  1991cited by this paper
• Comparative antioxidant activities of propranolol, nifedipine, verapamil, and diltiazem against sarcolemmal membrane lipid peroxidation.

  1990cited by this paper
• A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure.

  1990cited by this paper
• Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

  1990cited by this paper
• Response of the coronary vasculature to myocardial hypertrophy.

  1990cited by this paper
• Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

  1990cited by this paper
• A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis.

  1990cited by this paper
• Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT). INTACT Group Investigators.

  1990cited by this paper
• Significance of hyperventilation-induced ST segment depression in patients with coronary artery disease.

  1989cited by this paper
• Early treatment of unstable angina in the coronary care unit: a randomised, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both.

  1988cited by this paper
• Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure.

  1987cited by this paper
• Nisoldipine After Acute Myocardial Infarction: Comparison with Other Calcium Channel Blocking Agents

  1987cited by this paper
• Effects of verapamil and nifedipine on rate of left ventricular relaxation in coronary arterial disease patients.

  1987cited by this paper
• Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.

  1987cited by this paper
• Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy.

  1987cited by this paper
• Calcium antagonists and the ischemic myocardium.

  1987cited by this paper
• Trial of early nifedipine in acute myocardial infarction: the Trent study.

  1986cited by this paper
• Effect of early treatment with nifedipine in suspected acute myocardial infarction.

  1986cited by this paper
• Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin.

  1986cited by this paper
• Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial.

  1986cited by this paper
• Mixed angina pectoris.

  1985cited by this paper
• Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

  1985cited by this paper
• Effects of verapamil in preventing early postinfarction angina and reinfarction.

  1985cited by this paper
• Nifedipine therapy for patients with threatened and acute myocardial infarction: a randomized, double-blind, placebo-controlled comparison.

  1984cited by this paper
• Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.

  1984cited by this paper
• Nifedipine and conventional therapy for unstable angina pectoris: a randomized, double-blind comparison.

  1984cited by this paper
• Verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

  1984cited by this paper
• Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: the Norwegian Nifedipine Multicenter Trial.

  1984cited by this paper
• Nifedipine in acute myocardial infarction.

  1984cited by this paper
• Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.

  1983cited by this paper
• Protection of Infarcting Myocardium by Slow Channel Inhibitors: Comparative Effects of Verapamil, Nifedipine, and Diltiazem in the Coronary‐Ligated, Isolated Working Rat Heart

  1983cited by this paper
• Reduktion der CK- und CKMB-Infarktgröße durch Verapamil

  1983cited by this paper
• Efficacy, duration and mechanism of action of nifedipine in stable exercise-induced angina pectoris.

  1983cited by this paper
• Superiority of Verapamil to Propranolol in Stable Angina Pectoris A Double-blind, Randomized Crossover Trial

  1982cited by this paper
• Protection of the myocardium against postischemic reperfusion damage. The combined effect of hypothermia and nifedipine.

  1982cited by this paper
• Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography.

  1982cited by this paper
• Nifedipine in unstable angina: a double-blind, randomized trial.

  1982cited by this paper
• Verapamil versus propranolol for angina at rest.

  1982cited by this paper
• Exercise-induced coronary spasm with S-T segment depression and normal coronary arteriography.

  1981cited by this paper
• Therapy of coronary vasoconstriction in patients with coronary artery disease.

  1981cited by this paper
• The beneficial effect of a calcium channel blocker, Diltiazem, on the ischemic-reperfused heart.

  1980cited by this paper
• Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

  1980cited by this paper
• Circadian Variation of Exercise Capacity in Patients with Prinzmetal's Variant Angina: Role of Exercise‐induced Coronary Arterial Spasm

  1979cited by this paper
• Effects of verapamil on myocardial performance in coronary disease.

  1979cited by this paper
• Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina.

  1978cited by this paper
• Angina pectoris. I. A variant form of angina pectoris; preliminary report.

  1959cited by this paper
• Placebo controlled trial of felodipine in patients with mild to moderate heart failure

  year unknowncited by this paper

• Hibiscus sabdariffa Linn. (Roselle) protects against nicotine-induced heart damage in rats

  2016cites this paper
• Coronary Artery Vasomotion and Post-Stenotic Coronary Artery Blood Flow after Intracoronary Lacidipine in Patients with Ischaemic Heart Disease

  2012cites this paper
• Mechanoelectric Transduction/Feedback: Physiology and Pathophysiology

  2007cites this paper
• Clinical Communications: Adults 'SILENT' PRINZMETAL'S ST ELEVATION RELATED TO ATENOLOL OVERDOSE

  2007cites this paper
• Mechanosensitive‐Mediated Interaction, Integration, and Cardiac Control

  2006cites this paper
• Antianginal effects of lercanidipine on the vasopressin or methacholine induced anginal model in rats.

  2005cites this paper
• A Randomized, Double-Blind Comparison of Lercanidipine 10 and 20 mg in Patients with Stable Effort Angina: Clinical Evaluation of Cardiac Function by Ambulatory Ventricular Scintigraphic Monitoring

  2004cites this paper
• Endothelin-1 Promotes Ca2+ Antagonist-Insensitive Coronary Smooth Muscle Contraction Via Activation of &egr;-Protein Kinase C

  2004cites this paper
• Contraction Via Activation of Antagonist-Insensitive Coronary Smooth Muscle 2 + Endothelin-1 Promotes Ca

  2004cites this paper
• Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of ϵ-protein kinase C-dependent pathway

  2003cites this paper
• Ca2+ antagonist-insensitive coronary smooth muscle contraction involves activation of epsilon-protein kinase C-dependent pathway.

  2003cites this paper
• Effects of Intravenous Amlodipine on Coronary Hemodynamics in Subjects with Angiographically Normal Coronary Arteries

  2002cites this paper
• A Randomized, Double-Blind Comparison of 10 and 20 mg Lercanidipine in Patients With Stable Effort Angina: Effects on Myocardial Ischemia and Heart Rate Variability

  2002influential citation
• [The use of combination therapy with lacidipine and beta-adrenoblockers in patients with hypertension].

  2002cites this paper
• Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension.

  2001cites this paper
• Markers of electrical instability in hypertensive patients with and without ventricular arrhythmias. Are they useful in identifying patients with different risk profiles?

  2000cites this paper
• Mechanosensitivity as an integrative system in heart: an audit.

  1999cites this paper
• Current status of calcium channel blockers in patients with cardiovascular disease.

  1999cites this paper
• Management of unstable angina

  1998cites this paper
• The Classification of Calcium Antagonists and their Selection in the Treatment of Hypertension

  1998cites this paper
• [Calcium antagonists in ischemic heart disease].

  1997cites this paper
• Increased Urinary cGMP and Decreased Albumin Excretion with Isradipine Treatment in Essential Hypertension

  1997cites this paper